ArticleAngewandte Chemie (International ed. in English)2026
Assembly of Protein-DNA Framework Nanostructures: Structurally Defining Protein-DNA Interfaces With Aptamer.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DNA and proteins have been extensively explored for self-assembly of nanostructures. Each has its own advantages and limitations. By integrating them together, protein-DNA frameworks (PDFs) could potentially combine their advantages while overcoming the limitations associated with each component; thus, providing a huge diversity in terms of structures, functionalities, assembly versatilities, and responsiveness. Though each has been demonstrated to self-assemble into large structures, it remains a great challenge to engineer well-structured protein-DNA interfaces for PDF assembly. Herein, we report a robust and versatile approach to this problem. Specific and high-affinity protein-aptamer binding can nicely interface protein and DNA with structural control. A series of bivalent thrombin aptamers were designed to co-assemble with thrombin into a range of PDFs including discrete triangles and 3D prisms, linear and circular oligomers, 1D chains/ladders, and 2D arrays. The versatility of such a strategy was further demonstrated by the self-assembly of Plasmodium falciparum lactate dehydrogenase (PfLDH)-containing PDFs. In this work, AlphaFold 3, a universal modeling program, dramatically facilitates structural modeling and helps the designs. We believe that such a rational PDF design will find wide applications as multimodal biomaterials integrating the diverse functionalities of proteins and the ease of assembly programmability of DNA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.